We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 85.56+0.3%10:45 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patlawche11 who wrote (45901)4/25/2018 2:32:02 PM
From: patlawche113 Recommendations

Recommended By

  Read Replies (1) of 58277
FWIW...IMMU132 status changed today from active, recruiting to active, not recruiting for Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers. So...I would imagine they are currently not treating new/additional patients for UC, as well as for other indications in this trial.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext